A novel protein developed by Northwestern Medicine investigators improved survival and prevented brain infection in mice infected with SARS-CoV-2 when administered intranasally, according to a recent study.
Ann & Robert H. Lurie Children’s Hospital of Chicago is the first in Illinois to receive designation as a NORD Rare Disease Center of Excellence, becoming one of 40 U.S. academic medical centers selected to be a part of the first-of-it-kind national network of U.S. medical institutions dedicated to diagnosing, treating, and researching all rare…
Richard Silverman, PhD, along with two other Northwestern faculty members, has been elected to the National Academy of Sciences.
Patients with endometrial cancer who received the immunotherapy drug pembrolizumab in addition to chemotherapy had longer progression-free survival compared to chemotherapy alone, according to a recent clinical trial published in the New England Journal of Medicine.
Northwestern University Feinberg School of Medicine has launched the new Simpson Querrey Lung Institute for Translational Science (SQLIFTS), ushering in a new era of lung research, education, and patient care at Northwestern Medicine.
Secondary bacterial pneumonia that did not resolve was a key driver of death in patients with COVID-19, according to a recent study in the Journal of Clinical Investigation.
Northwestern investigators have demonstrated that fine-tuning DNA interaction strength can improve colloidal crystal engineering to enhance their use in creating an array of functional nanomaterials.
A Northwestern Medicine study used a novel ultrasound device to temporarily open the blood-brain barrier to deliver chemotherapy to treat glioblastoma.
An iPad app developed by Northwestern Medicine investigators that helps measure specific aspects of cognitive, motor, sensory and emotional function in five minutes or less is now available for doctors to screen people ages 3 to 85+ for a wide range of neurological diseases and syndromes.
Northwestern Medicine scientists have developed a biomarker signature test to predict which tumors will respond to immunotherapy.